has approved Iluvien ® (fluocinolone acetonide intravitreal implant) for the treatment of chronic non-infectious uveitis affecting the posterior segment of the eye. Iluvien is a sterile ...
The FDA approved an expanded label for Iluvien, which is now indicated for the treatment of chronic noninfectious uveitis ...
has approved an expanded label for Iluvien (fluocinolone acetonide intravitreal implant) that includes an indication for the treatment of chronic non-infectious uveitis affecting the posterior segment ...
has approved an updated label for ILUVIEN, a fluocinolone acetonide intravitreal implant, to include treatment for chronic non-infectious uveitis affecting the posterior segment of the eye (NIU-PS).
the treatment of chronic non-infectious uveitis affecting the posterior segment of the eye. ILUVIEN is contraindicated in patients with active or suspected ocular or periocular infections ...
ILUVIEN is approved for treating diabetic macular edema (DME) and chronic non-infectious uveitis affecting the posterior segment of the eye. When will ILUVIEN be marketed in the U.S.? ANI ...
ILUVIEN now approved for the treatment of chronic non-infectious uveitis affecting the posterior segment of the eye (NIU-PS) in addition to diabetic macular edema (DME) ANI plans to begin ...
has approved an updated label for ILUVIEN, a fluocinolone acetonide intravitreal implant, to include treatment for chronic non-infectious uveitis affecting the posterior segment of the eye (NIU-PS).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback